PillCytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex Ii Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
Brands: Viri Sode · Human Herpesvirus 5 + Human Herpesvirus 1 + Human Herpesvirus 2 + Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1n1) Antigen (Formaldehyde Inactivated) + Influenza A Virus A/Thailand/8/2022 Ivr-237 (H3n2) Antigen (Formaldehyde Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Whole + Influenza B Virus B/Phuket/3073/2013 Bvr-1b Whole + Rubella Virus + Hepatitis A Virus + Hepatitis B Virus + Hepatitis C Virus + Human Herpesvirus 4 + Human Herpesvirus 3
0 active makers
soon
soon
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Nutritional Specialties, Inc. | unknown | 1 | EXITED 2030 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.